GSK/Ranbaxy Deal Gives Indian Firm Greater Development Charge
This article was originally published in The Pink Sheet Daily
Executive Summary
Under expansion of 2003 deal, Indian firm will take targets to proof of concept, gaining milestones, possible royalties.